RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

The RAPS store will be under maintenance Saturday, 6 June between 6 AM and 12 PM EST. Store functionality may be unavailable at times during this window.
We apologize for any inconvenience caused during this time.

Regulatory Focus™ > News Articles > Canada: New eCTD Guidance In Effect

Canada: New eCTD Guidance In Effect

Posted 02 April 2012 | By Ansis Helmanis

Health Canada issued Draft Guidance on 30 March on the Preparation of Drug Regulatory Activities in electronic Common Technical Documents (eCTDs). The guidance, which provides more options for sponsors of submissions, is effective immediately since it does not impose any new obligations. The exception to immediate effect-section 3.4.1 Module 1: Administrative and Product Information-will only be usable when the revised Canadian Module 1 Schema is published and adopted. 

Read more:

Consultation Document - Draft Guidance Document: Preparation of Drug Regulatory Activities in Electronic Common Technical Document (eCTD)

Regulatory Focus newsletters

All the biggest regulatory news and happenings.